PEDEVCO CORP (PED)

US70532Y3036 - Common Stock

0.8579  -0.09 (-9.21%)

After market: 0.88 +0.02 (+2.58%)

Fundamental Rating

5

Overall PED gets a fundamental rating of 5 out of 10. We evaluated PED against 208 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for PED as it has an excellent financial health rating, but there are worries on the profitability. PED is valued quite expensively, but it does show have an excellent growth rating.



3

1. Profitability

1.1 Basic Checks

In the past year PED was profitable.
In the past year PED had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PED reported negative net income in multiple years.
Each year in the past 5 years PED had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.35%, PED is doing worse than 75.48% of the companies in the same industry.
PED has a Return On Equity of 0.37%. This is in the lower half of the industry: PED underperforms 73.56% of its industry peers.
PED has a Return On Invested Capital of 3.13%. This is in the lower half of the industry: PED underperforms 72.12% of its industry peers.
Industry RankSector Rank
ROA 0.35%
ROE 0.37%
ROIC 3.13%
ROA(3y)0.45%
ROA(5y)-9.75%
ROE(3y)0.6%
ROE(5y)-10.39%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PED's Profit Margin of 1.13% is on the low side compared to the rest of the industry. PED is outperformed by 71.63% of its industry peers.
In the last couple of years the Profit Margin of PED has declined.
PED has a Operating Margin of 12.35%. This is in the lower half of the industry: PED underperforms 63.46% of its industry peers.
With a decent Gross Margin value of 68.79%, PED is doing good in the industry, outperforming 75.48% of the companies in the same industry.
In the last couple of years the Gross Margin of PED has grown nicely.
Industry RankSector Rank
OM 12.35%
PM (TTM) 1.13%
GM 68.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-76.46%
GM growth 3Y14.86%
GM growth 5Y12.6%

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PED is destroying value.
PED has more shares outstanding than it did 1 year ago.
PED has more shares outstanding than it did 5 years ago.
PED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 5.45 indicates that PED is not in any danger for bankruptcy at the moment.
PED's Altman-Z score of 5.45 is amongst the best of the industry. PED outperforms 90.38% of its industry peers.
There is no outstanding debt for PED. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.45
ROIC/WACC0.37
WACC8.37%

2.3 Liquidity

PED has a Current Ratio of 2.94. This indicates that PED is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.94, PED is in the better half of the industry, outperforming 79.81% of the companies in the same industry.
PED has a Quick Ratio of 2.94. This indicates that PED is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.94, PED belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 2.94

7

3. Growth

3.1 Past

PED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
The earnings per share for PED have been decreasing by -77.03% on average. This is quite bad
The Revenue has grown by 12.92% in the past year. This is quite good.
The Revenue has been growing by 46.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5Y-77.03%
EPS Q2Q%-25%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y56.31%
Revenue growth 5Y46.77%
Sales Q2Q%8.26%

3.2 Future

PED is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.07% yearly.
The Revenue is expected to grow by 18.09% on average over the next years. This is quite good.
EPS Next Y-17.28%
EPS Next 2Y11.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.13%
Revenue Next 2Y18.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

PED is valuated rather expensively with a Price/Earnings ratio of 17.16.
Based on the Price/Earnings ratio, PED is valued a bit more expensive than 64.90% of the companies in the same industry.
PED is valuated rather cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.93, the valuation of PED can be described as very reasonable.
PED's Price/Forward Earnings is on the same level as the industry average.
PED's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.22.
Industry RankSector Rank
PE 17.16
Fwd PE 9.93

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PED is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.52

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PED!.
Industry RankSector Rank
Dividend Yield N/A

PEDEVCO CORP

NYSEARCA:PED (9/6/2024, 8:04:00 PM)

After market: 0.88 +0.02 (+2.58%)

0.8579

-0.09 (-9.21%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap76.60M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 17.16
Fwd PE 9.93
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.37%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.35%
PM (TTM) 1.13%
GM 68.79%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.94
Quick Ratio 2.94
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-17.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.92%
Revenue growth 3Y56.31%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y